Brucellosis

disease
On this page

Also known as Cyprus feverRock feverundulant fever

Summary

Brucellosis (MONDO:0005683) is a disease and 8 clinical trials. A subtype of primary bacterial infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Europe) [Orphanet-validated]
  • Phenotypes (HPO): 77
  • Clinical trials: 8

Clinical features

Epidemiology

Prevalence records

25 prevalence record(s), Orphanet, top 20 (validated / broadest geography first):

TypeClassValueGeographyValidation
Annual incidence<1 / 1 000 0000.09EuropeValidated
Annual incidence<1 / 1 000 0000.03FranceValidated
Annual incidence<1 / 1 000 0000.04AustriaValidated
Annual incidence<1 / 1 000 0000.05GermanyValidated
Annual incidence1-9 / 100 0001.13GreeceValidated
Annual incidence<1 / 1 000 0000.03IrelandValidated
Annual incidence1-9 / 1 000 0000.22ItalyValidated
Annual incidence<1 / 1 000 0000.01LithuaniaValidated
Annual incidence<1 / 1 000 0000.03LuxembourgValidated
Annual incidence<1 / 1 000 0000.05MaltaValidated
Annual incidence<1 / 1 000 0000.05NorwayValidated
Annual incidence1-9 / 1 000 0000.35PortugalValidated
Annual incidence1-9 / 1 000 0000.12SpainValidated
Annual incidence1-9 / 1 000 0000.15SwedenValidated
Annual incidence<1 / 1 000 0000.02United KingdomValidated
Annual incidence<1 / 1 000 0000.01RomaniaValidated
Annual incidence<1 / 1 000 0000.02SlovakiaValidated
Annual incidence<1 / 1 000 0000.02SloveniaValidated
Annual incidence<1 / 1 000 0000.02NetherlandsValidated
Annual incidence<1 / 1 000 0000.01PolandValidated

Signs & symptoms

Clinical features (HPO)

77 HPO clinical features (Orphanet curated; top 50 by frequency):

HPO IDTermFrequency
HP:0001392Abnormality of the liverVery frequent (80-99%)
HP:0000975HyperhidrosisFrequent (30-79%)
HP:0001369ArthritisFrequent (30-79%)
HP:0001744SplenomegalyFrequent (30-79%)
HP:0001824Weight lossFrequent (30-79%)
HP:0001882LeukopeniaFrequent (30-79%)
HP:0001903AnemiaFrequent (30-79%)
HP:0001945FeverFrequent (30-79%)
HP:0002018NauseaFrequent (30-79%)
HP:0002039AnorexiaFrequent (30-79%)
HP:0002240HepatomegalyFrequent (30-79%)
HP:0002829ArthralgiaFrequent (30-79%)
HP:0003095Septic arthritisFrequent (30-79%)
HP:0003237Increased circulating IgG levelFrequent (30-79%)
HP:0003565Elevated erythrocyte sedimentation rateFrequent (30-79%)
HP:0011024Abnormality of the gastrointestinal tractFrequent (30-79%)
HP:0011227Elevated circulating C-reactive protein concentrationFrequent (30-79%)
HP:0012378FatigueFrequent (30-79%)
HP:0025155Abnormality of hepatobiliary system physiologyFrequent (30-79%)
HP:0025406AstheniaFrequent (30-79%)
HP:0000031EpididymitisOccasional (5-29%)
HP:0000099GlomerulonephritisOccasional (5-29%)
HP:0000119Abnormality of the genitourinary systemOccasional (5-29%)
HP:0000707Abnormality of the nervous systemOccasional (5-29%)
HP:0000716DepressionOccasional (5-29%)
HP:0000951Abnormality of the skinOccasional (5-29%)
HP:0000979PurpuraOccasional (5-29%)
HP:0001508Failure to thriveOccasional (5-29%)
HP:0001518Small for gestational ageOccasional (5-29%)
HP:0001622Premature birthOccasional (5-29%)
HP:0001873ThrombocytopeniaOccasional (5-29%)
HP:0001971HypersplenismOccasional (5-29%)
HP:0001974LeukocytosisOccasional (5-29%)
HP:0002011Morphological central nervous system abnormalityOccasional (5-29%)
HP:0002013VomitingOccasional (5-29%)
HP:0002027Abdominal painOccasional (5-29%)
HP:0002090PneumoniaOccasional (5-29%)
HP:0002202Pleural effusionOccasional (5-29%)
HP:0002315HeadacheOccasional (5-29%)
HP:0002716LymphadenopathyOccasional (5-29%)
HP:0002754OsteomyelitisOccasional (5-29%)
HP:0002923Rheumatoid factor positiveOccasional (5-29%)
HP:0003496Increased circulating IgM levelOccasional (5-29%)
HP:0005086Knee osteoarthritisOccasional (5-29%)
HP:0005268Spontaneous abortionOccasional (5-29%)
HP:0005561Abnormality of bone marrow cell morphologyOccasional (5-29%)
HP:0008843Hip osteoarthritisOccasional (5-29%)
HP:0009830Peripheral neuropathyOccasional (5-29%)
HP:0012252Abnormal respiratory system morphologyOccasional (5-29%)
HP:0012317Sacroiliac arthritisOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namebrucellosis
Mondo IDMONDO:0005683
EFOEFO:0007185
MeSHD002006
Orphanet1304
DOIDDOID:11077
ICD-10-CMA23
ICD-11730510331
NCITC84602
SNOMED CT75702008
UMLSC0006309
MedGen674
GARD0005966
MedDRA10006500
NORD877
Is cancer (heuristic)no

Also known as: Cyprus fever · Rock fever · undulant fever

Disease family

This is a subtype of primary bacterial infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseasebacterial infectious diseaseprimary bacterial infectious diseasebrucellosis

Related subtypes (36): Buruli ulcer disease, sennetsu fever, salmonellosis, pinta disease, chancroid, gonorrhea, anthrax infection, leprosy, botulism, diphtheria, tetanus, bartonellosis, campylobacteriosis, glanders, granuloma inguinale, legionellosis, leptospirosis, listeriosis, Mycobacterium avium complex disease, ornithosis, rhinoscleroma, staphyloenterotoxemia, syphilis, cholera, ehrlichiosis, melioidosis, tuberculosis, tularemia, plague, Q fever, shigellosis, Lyme disease, relapsing fever, spirillary rat-bite fever, streptobacillary rat-bite fever, Borrelia miyamotoi disease

Subtypes (4): Brucella suis brucellosis, Brucella canis brucellosis, Brucella melitensis brucellosis, Brucella abortus brucellosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 8.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified8

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06859619Not specifiedNOT_YET_RECRUITINGSerological Measurement of Montpellier Professionals’ Contacts with Infectious Agents Responsible for Animal-borne Diseases
NCT07358910Not specifiedRECRUITINGRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
NCT01766830Not specifiedCOMPLETEDRapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
NCT04301752Not specifiedCOMPLETEDCognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis
NCT04717622Not specifiedUNKNOWNInvestigation of Fever Suspected as a Zoonosis Using Advanced Diagnostic Technologies
NCT04911283Not specifiedCOMPLETEDBrucella Serology and History of Brucellosis in Patients With Modic Changes Type 1
NCT06007326Not specifiedCOMPLETEDA Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With Brucellosis
NCT07112677Not specifiedCOMPLETEDSeroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.